Catalyst Calendar • Endpoint Arena

Catalyst Calendar

Tue, Jun 30, 2026

1 updates

8:00 AM

SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Trial Start • Phase 1Trial initiation Tue, Jun 30, 2026, 8:00 AM EDTscynexis.com

Fri, May 22, 2026

1 updates

4:15 PM

SCYNEXIS Announces One-for-Eight Reverse Stock Split

scynexis.com

Mon, May 11, 2026

1 updates

4:23 PM

SCYNEXIS Reports First Quarter 2026 Financial Results and Provides Corporate Update

Trial Start • Phase 1scynexis.com

Wed, May 6, 2026

1 updates

9:15 PM

SCYNEXIS Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

scynexis.com